Endoplasmic reticulum protein 29 (ERp29) as a novel prognostic marker and tumor suppressor in osteosarcoma
© 2019 Background: Diverse aberrancy in genetic background, protein profiling, and biological pathways have emerged as important factors hindering discovery of effective treatment of osteosarcoma. In a previous study, we used a proteomic approach to identify some osteosarcoma-related proteins by ana...
Saved in:
Main Authors: | Parunya Chaiyawat, Dumnoensun Pruksakorn, Prach Pipatwattana, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jeerawan Klangjorhor, Jongkolnee Settakorn |
---|---|
Format: | Journal |
Published: |
2019
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85063335327&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65737 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Expression patterns of class i histone deacetylases in osteosarcoma: A novel prognostic marker with potential therapeutic implications
by: Parunya Chaiyawat, et al.
Published: (2018) -
In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients
by: Jeerawan Klangjorhor, et al.
Published: (2020) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2018) -
Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2018) -
Expression profiling of DNA methyl transferase I (DNMT1) and efficacy of a DNA-hypomethylating agent (decitabine) in combination with chemotherapy in osteosarcoma
by: Parunya Chaiyawat, et al.
Published: (2020)